H.PIO Co., Ltd. (KOSDAQ:357230)
South Korea · Delayed Price · Currency is KRW 2,195.00
+65.00 (3.05%)
At close: Jul 10, 2026
H.PIO Market Cap
H.PIO has a market cap or net worth of 90.6 billion as of July 10, 2026. Its market cap has decreased by -14.26% in one year.
Market Cap
90.60B
Enterprise Value
100.38B
Revenue
266.01B
Ranking
n/a
PE Ratio
9.42
Stock Price
2,195.00
Market Cap Chart
Since May 14, 2021, H.PIO's market cap has decreased from 333.96B to 90.60B, a decrease of -72.87%. That is a compound annual growth rate of -22.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 90.60B | -9.30% |
| Dec 30, 2025 | 99.89B | -1.21% |
| Dec 30, 2024 | 101.11B | -37.21% |
| Dec 28, 2023 | 161.03B | 11.36% |
| Dec 29, 2022 | 144.60B | -46.67% |
| Dec 30, 2021 | 271.16B | -18.81% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 106.80B |
| OPTUS Pharmaceutical | 105.53B |
| BL Pharmtech | 101.73B |
| DongKoo Bio & Pharma | 101.54B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 87.12B |
| KOREA PHARMA | 86.82B |
| Daehan Nupharm | 80.42B |
| Sam-A Pharm. | 78.24B |